InvestorsHub Logo
Followers 14
Posts 708
Boards Moderated 0
Alias Born 08/21/2012

Re: 1776club post# 9570

Monday, 04/12/2021 8:56:14 AM

Monday, April 12, 2021 8:56:14 AM

Post# of 14947
Regeneron CEO on CNBC discussing how effective their antibody is, including prevention. Thanks Dr. Ji.

ZURICH (Reuters) -Regeneron is pursuing U.S. approval for its COVID-19 monoclonal antibody cocktail as a preventative treatment after it helped cut the risk of symptomatic infections in households where someone else is ill, the U.S. drugmaker said on Monday.

REGEN-COV, a combination of casirivimab and imdevimab, protected household contacts from exposure to SARS-CoV-2, with 72% protection against symptomatic infections in the first week, and 93% after that, according to trial data released by the company.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News